Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Peptris Technologies logo — AI plays tetris with proteins

Peptris Technologies

AI plays tetris with proteins

Founded 2019 India Bengaluru, India 11 employees Pre-Seed Total: $1.00M AI, Biotechnology

General Information

Company Name Peptris Technologies
Founded Year 2019
Location India Bengaluru, India
Employees 11
Industries AI, Biotechnology
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Peptris Technologies. To contact Peptris Technologies, visit peptris.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Peptris Technologies compare?

A PDF of Peptris Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Peptris Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Peptris Technologies

Peptris Technologies is a biotechnology startup with a slogan "AI plays tetris with proteins". Founded in 2019 and headquartered in India, Peptris is utilizing AI for preclinical drug discovery in the fields of oncology, inflammation, and rare diseases. The company has developed a range of AI models to forecast crucial parameters for identifying potential drug candidates. These models are managed by an automated pipeline that streamlines large purchasable compound datasets to pinpoint potential hits and generate novel compound variations. This process minimizes the number of compounds requiring wet lab testing, leading to efficient, rapid, and cost-effective drug discovery. The startup recently secured a $1.00M Pre Seed Round investment on 19 December 2023 from Speciale Invest, demonstrating investors' confidence in Peptris' innovative approach to drug discovery. With promising wet lab results from its proprietary discovery programs, Peptris is actively transitioning these findings into preclinical development. The company's focus on leveraging AI and automation to enhance drug discovery efficiency sets it apart in the biotechnology landscape, making it an exciting prospect for potential investors seeking innovative solutions in the field.

Business keywords: Drug Discovery, Preclinical Research, Oncology, Inflammation, Rare Diseases, AI Models, Compound Datasets, Wet Lab Testing, Preclinical Development, Automated Pipeline, De Novo Variations, Predictive Modeling, Cost Effective, Efficient

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $1.00M 1
Speciale Invest
Speciale Invest
19 Dec 2023

Peptris Technologies Alternatives & Competitors

View All Alternatives
Peptris Technologies vs
Micar Innovation (Micar21)
Micar Innovation (Micar21) Bulgaria

Micar Innovation - Drug Discovery Factory for novel drug molecules (structure based in silico drug d...

3 employees
AI, Biotechnology
Peptris Technologies vs
Numerate
Numerate

Elevating Drug Discovery Through Advanced Computational Innovation

Series C
5 employees
AI, Biotechnology
Peptris Technologies vs
Simmunome Inc.
Simmunome Inc. Canada

Move your pipeline forward, with confidence.

Pre-Seed
10 employees
AI, Biotechnology
View all alternatives

FAQ About Peptris Technologies

AI plays tetris with proteins
Peptris Technologies was founded in 2019.
Peptris Technologies is headquartered in Bengaluru, India.
Peptris Technologies operates in AI and Biotechnology. Its work centres on Drug Discovery, Preclinical Research, Oncology and Inflammation.
Peptris Technologies has approximately 11 employees.
Peptris Technologies has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Peptris Technologies include Micar Innovation (Micar21), Numerate, Simmunome Inc., InVivoCloud - AI Platform, 1910 Genetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Peptris Technologies and Micar Innovation (Micar21) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Peptris Technologies, https://bouncewatch.com/company/peptris-technologies, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes